Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001719EBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10006549HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10008067HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10008068HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30003991HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30079115HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30087748HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30081211HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30081546HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30082146HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TCGA Plot Options
Drug Information
GeneEGFR
DrugBank IDDB08916
Drug NameAfatinib
Target IDBE0000767
UniProt IDP00533
Regulation Typeinhibitor
PubMed IDs31558282; 34104899
CitationsMasood A, Kancha RK, Subramanian J: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib. Semin Oncol. 2019 Jun;46(3):271-283. doi: 10.1053/j.seminoncol.2019.08.004. Epub 2019 Sep 11.@@Vasconcelos PENS, Gergis C, Viray H, Varkaris A, Fujii M, Rangachari D, VanderLaan PA, Kobayashi IS, Kobayashi SS, Costa DB: EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors. JTO Clin Res Rep. 2020 Sep;1(3). doi: 10.1016/j.jtocrr.2020.100051. Epub 2020 May 13.
GroupsApproved
Direct ClassificationQuinazolinamines
SMILESCN(C)CC=CC(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1
Pathways
PharmGKBPA165981154
ChEMBLCHEMBL1173655